James Sidoti
Stock Analyst at Sidoti & Co.
(2.87)
# 1,479
Out of 5,182 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $25.67 | +9.08% | 3 | Aug 5, 2025 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $150 | $1.67 | +8,882.04% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $113.45 | -70.03% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $15.37 | +296.88% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $25.67
Upside: +9.08%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $150
Current: $1.67
Upside: +8,882.04%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $113.45
Upside: -70.03%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $15.37
Upside: +296.88%